NDC 62157-948 - Mirtazapine Anhydrous
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62157-948
- Package NDCs from labels
- 62157-948-01
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2020-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mirtazapine Anhydrous - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2020-01-13 | BULK INGREDIENT |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mirtazapine | MIRTAZAPINE | Proficient Rx LP | 3b516a33-b164-4e4f-bc18-e9d1e591323a | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | Proficient Rx LP | 0f19ab40-1a30-4ac2-9bd7-c2f8199e29e1 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | Proficient Rx LP | a2f01ffd-fd48-499b-9126-8eb9048a5722 | 2022-05-02 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | Sun Pharmaceutical Industries, Inc. | f23631be-c7ae-46e9-b771-a70be17bc9f0 | 2021-11-30 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | Aphena Pharma Solutions - Tennessee, LLC | 500dbfbe-2a00-496d-9e44-6e59d2c68ea2 | 2021-08-20 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | Proficient Rx LP | a96e0d95-1a7b-4588-923a-2169b5506203 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | Aphena Pharma Solutions - Tennessee, LLC | 93c4ddcf-ca4f-4a46-a7b7-1395fb0885d2 | 2020-11-11 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | NCS HealthCare of KY, Inc dba Vangard Labs | 20a724c6-feba-40e7-a35a-8a37de2e0136 | 2019-03-08 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | Aphena Pharma Solutions - Tennessee, LLC | 3bda4994-cdf5-47b4-aebc-7297347334e9 | 2018-08-24 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
| Mirtazapine | MIRTAZAPINE | Aphena Pharma Solutions - Tennessee, LLC | 6ad0e695-92ee-4900-b194-a2455473370b | 2018-07-31 | Boxed warning, Warnings, Adverse reactions | A051Q2099Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.